[HTML][HTML] Financial burden of tuberculosis diagnosis and treatment for patients in Ethiopia: a systematic review and meta-analysis
DG Assefa, ZG Dememew, ED Zeleke, T Manyazewal… - BMC Public Health, 2024 - Springer
Background Despite the diagnosis and treatment of tuberculosis (TB) given free of charge in
many high-burden countries, the costs that patients face in the cascade of care remain a …
many high-burden countries, the costs that patients face in the cascade of care remain a …
[HTML][HTML] Financial hardship among patients suffering from neglected tropical diseases: A systematic review and meta-analysis of global literature
C Patikorn, JY Cho, J Higashi, XX Huang… - PLOS Neglected …, 2024 - journals.plos.org
Introduction Neglected tropical diseases (NTDs) mainly affect underprivileged populations,
potentially resulting in catastrophic health spending (CHS) and impoverishment from out-of …
potentially resulting in catastrophic health spending (CHS) and impoverishment from out-of …
Effect of digital medication event reminder and monitor-observed therapy vs standard directly observed therapy on health-related quality of life and catastrophic costs …
Importance Little is known about whether digital adherence technologies are economical for
patients with tuberculosis (TB) in resource-constrained settings. Objective To test the …
patients with tuberculosis (TB) in resource-constrained settings. Objective To test the …
[HTML][HTML] ClpC2 protects mycobacteria against a natural antibiotic targeting ClpC1-dependent protein degradation
G Taylor, H Cui, J Leodolter, C Giese… - Communications …, 2023 - nature.com
Mycobacterium tuberculosis Clp proteases are targeted by several antitubercular
compounds, including cyclomarin A (CymA). CymA exerts its toxicity by binding to AAA+ …
compounds, including cyclomarin A (CymA). CymA exerts its toxicity by binding to AAA+ …
The potential impact of novel tuberculosis vaccines on health equity and financial protection in low-income and middle-income countries
A Portnoy, RA Clark, CK Weerasuriya… - BMJ global …, 2023 - gh.bmj.com
Introduction One in two patients developing tuberculosis (TB) in low-income and middle-
income countries (LMICs) faces catastrophic household costs. We assessed the potential …
income countries (LMICs) faces catastrophic household costs. We assessed the potential …
[HTML][HTML] Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of …
Background Global evaluations of the progress towards the WHO End TB Strategy 2020
interim milestones on mortality (35% reduction) and incidence (20% reduction) have not …
interim milestones on mortality (35% reduction) and incidence (20% reduction) have not …
[HTML][HTML] Survey to measure the quality of life of patients with tuberculosis in Alexandria, Egypt: a cross-sectional study
EA Hammouda, WF Gobran, RM Tawfeek… - BMC Health Services …, 2023 - Springer
Background Assessment of quality of life (QoL) in patients with tuberculosis (TB) may
improve healthcare providers' understanding of the disease burden. This study aimed to …
improve healthcare providers' understanding of the disease burden. This study aimed to …
[HTML][HTML] Catastrophic costs among tuberculosis-affected households in Egypt: Magnitude, cost drivers, and coping strategies
Despite national programs covering the cost of treatment for tuberculosis (TB) in many
countries, TB patients still face substantial costs. The end TB strategy, set by the World …
countries, TB patients still face substantial costs. The end TB strategy, set by the World …
[HTML][HTML] Economic burden of multidrug-resistant tuberculosis on patients and households: a global systematic review and meta-analysis
Multidrug-resistant tuberculosis (MDR-TB) is a major health threat worldwide, causing a
significant economic burden to patients and their families. Due to the longer duration of …
significant economic burden to patients and their families. Due to the longer duration of …
[HTML][HTML] Understanding the contribution of metabolism to Mycobacterium tuberculosis drug tolerance
AN Samuels, ER Wang, GA Harrison… - Frontiers in cellular …, 2022 - frontiersin.org
Treatment of Mycobacterium tuberculosis (Mtb) infections is particularly arduous. One
challenge to effectively treating tuberculosis is that drug efficacy in vivo often fails to match …
challenge to effectively treating tuberculosis is that drug efficacy in vivo often fails to match …